Risk Factors and Prognostic Retrospective Study of COVID-19 Morbidity among OPD Patients at Saraburi Hospital’s Triage Center : A 14-Day Post Diagnosis Study

Authors

  • Supanat Vanichaniramol, MD Department of Social Medicine, Saraburi Hospital
  • Saran Weerametachai, MD Department of Social Medicine, Saraburi Hospital
  • Thanakamon Leesri, Ph.D. School of Community Health Nursing, Institute of Nursing, Suranaree University of Technology

Keywords:

Covid-19, Morbidity rate, Risk factors

Abstract

Due to the coronavirus disease 2019 outbreak, the number of the SARs-CoV2-patients have been rapidly increasing, resulting in delayed treatments of many patients from inadequate medical resources. The more patients with delayed treatment, the more increasing risk of severe respiratory syndrome. To effectively distribute of medical resources, risk factors contributing to the severity are necessary to be assessed. This study’s objectives were to examine the incidence of morbidity and factors related to the morbidity of the 2019 coronavirus disease patients who come to receive services at the Comprehensive Covid Detection and Sorting Center, Saraburi. The retrospective cohort collected data from The Saraburi One-stop COVID Screening & Triage Center between 23 August 2021 to 5 September 2021. The incident rate of morbid patients was only obtained during 14 days after diagnosis. Multivariable Cox proportional-hazard regression was used to determine risk factors of morbidity, P-value ≤ 0.05 was considered as statistically significant.

The result of this study showed that a total of 1,026 SAR-CoV2 infected patients who received services from The Saraburi One-stop COVID Screening & Triage Center between 23 August 2021 to 5 September 2021. The prevalence of morbidity is 111 cases, representing a morbidity rate of 0.01 person/person-day. There was no mortality during the time of this study. The risk factors of morbidity were those aged over 60 (Hazard ratio=2.05, p-value=0.004), diabetes (Hazard ratio=2.11, p-value=0.011) and breathlessness/pleuritic chest pain (Hazard ratio=2.55, p-value<0.001.

Author Biographies

Supanat Vanichaniramol, MD, Department of Social Medicine, Saraburi Hospital

Medical Physician, Practitioner Level

Saran Weerametachai, MD, Department of Social Medicine, Saraburi Hospital

Medical Physician, Professional Level

Thanakamon Leesri, Ph.D., School of Community Health Nursing, Institute of Nursing, Suranaree University of Technology

Assistant Professor

References

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. doi: 10.1056/NEJMoa2002032.

Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 7;323(13):1239-42. doi: 10.1001/jama.2020.2648.

World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, [Internet]. 2021 [cited 2021 Oct 23]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5.

ชนเมธ เตชะแสนศิริ, ฐากูร วิริยะชัย. Pathogenesis of COVID-19 สมาคมโรคติดเชื้อในเด็กแห่งประเทศไทย (Pediatric Infectious Disease Society of Thailand) [อินเตอร์เน็ต]. 2564 [เข้าถึงเมื่อ 2564 ธ.ค. 25]. เข้าถึงได้จาก: https://research.tu.ac.th/uploads/research_admin /pdf/annual_report/AnnualReport%202554.pdf

สำนักงานสาธารณสุขจังหวัดสระบุรี. รายงานสถานการณ์โรคโควิด 19 ในสระบุรี [อินเตอร์เน็ต]. 2564 [เข้าถึงเมื่อ 2564 ธ.ค. 28] เข้าถึงได้จาก: https://sri.hdc.moph.go.th/covid19/index.php

กรมควบคุมโรค. โรคติดเชื้อโคโรนาไวรัส 2019, สถานการณ์ในประเทศไทย [อินเตอร์เน็ต]. 2564 [เข้าถึงเมื่อ 2564 ธ.ค. 28] เข้าถึงได้จาก: https://ddc.moph.go.th/viralpneumonia/index.php

กรมควบคุมโรค. นิยามผู้สงสัยติดเชื้อไวรัสโคโรนา 2019 ที่เข้าเกณฑ์สอบสวนโรค (Patient Under Investigation: PUI) [อินเตอร์เน็ต]. 2564 [เข้าถึงเมื่อ 2564 ก.ย. 6] เข้าถึงได้จาก: https://ddc.moph.go.th/viralpneumonia/g_srrt.php

Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81(2):e16-e25. doi: 10.1016/j.jinf.2020.04.021.

Kim HJ, Hwang H, Hong H, Yim JJ, Lee J. A systematic review and meta-analysis of regional risk factors for critical outcomes of COVID-19 during early phase of the pandemic. Sci Rep. 2021;11(1):9784. doi: 10.1038/s41598-021-89182-8.

Li D, Liu C, Liu J, Hu J, Yang Y, Zhou Y. Analysis of Risk Factors for 24 Patients with COVID-19 Developing from Moderate to Severe Condition. Front Cell Infect Microbiol. 2020;10:548582. doi: 10.3389/fcimb.2020.548582.

Bruminhent J, Ruangsubvilai N, Nabhindhakara J, Ingsathit A, Kiertiburanakul S. Clinical characteristics and risk factors for coronavirus disease 2019 (COVID-19) among patients under investigation in Thailand. PLoS One. 2020;15(9):e0239250.

WHO. Tracking SARS-CoV-2 variants [Internet]. 2021 [cited 2021 Oct. 27] Available form: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/

Gue YX, Tennyson M, Gao J, Ren S, Kanji R, Gorog DA. Author Correction: Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19. Sci Rep. 2021;11(1):8011. doi: 10.1038/s41598-021-87439-w.

Cho SY, Park SS, Song MK, Bae YY, Lee DG, Kim DW. Prognosis Score System to Predict Survival for COVID-19 Cases: a Korean Nationwide Cohort Study. J Med Internet Res. 2021;23(2):e26257. doi: 10.2196/26257.

Hajifathalian K, Sharaiha RZ, Kumar S, Krisko T, Skaf D, Ang B, et al.. Development and external validation of a prediction risk model for short-term mortality among hospitalized U.S. COVID-19 patients: A proposal for the COVID-AID risk tool. PLoS One. 2020;15(9):e0239536. doi: 10.1371/journal.pone.0239536.

Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol. 2020;146(1):1-7.

Coronavirus Disease 2019 (COVID-19) Treatment Guidelines [Internet]. Bethesda (MD): National Institutes of Health (US); 2021.

Abbasi E, Mirzaei F, Tavilani H, Khodadadi I. Diabetes and COVID-19: Mechanism of pneumonia, treatment strategy and vaccine. Metabol Open. 2021;11:100122.

Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021;76(2):428-455.

Zhang JJ, Cao YY, Tan G, Dong X, Wang BC, Lin J, et al. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients. Allergy. 2021;76(2):533-50. doi: 10.1111/all.14496.

Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. 2020;323(16):1612-4. doi: 10.1001/jama.2020.4326.

Kang SH, Cho DH, Choi J, Baik SK, Gwon JG, Kim MY. Association between chronic hepatitis B infection and COVID-19 outcomes: A Korean nationwide cohort study. PLoS One. 2021;16(10):e0258229. doi: 10.1371/journal.pone.0258229.

Downloads

Published

2022-03-28

How to Cite

Vanichaniramol, S., Weerametachai, S., & Thanakamon Leesri, T. L. (2022). Risk Factors and Prognostic Retrospective Study of COVID-19 Morbidity among OPD Patients at Saraburi Hospital’s Triage Center : A 14-Day Post Diagnosis Study. REGIONAL HEALTH PROMOTION CENTER 9 JOURNAL, 16(2), 343–355. retrieved from https://he02.tci-thaijo.org/index.php/RHPC9Journal/article/view/256011

Issue

Section

Research Article